Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Cen Biotech Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Cen Biotech Inc (CENB) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2021
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q3 2021
Revenue Growth Y/Y
-
Q3 2021
Net Margin
-264.15 %
Q3 2021

Key Findings: Cen Biotech Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 1M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-20.7% annualized vs trailing 12 months).
  • Peer revenue share: Cen Biotech Inc accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CENB Sales vs. its Competitors, Q3 2021

Cen Biotech Inc generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CENB/competitors
https://api.csimarket.com/api/v1/companies/CENB/relationships
https://api.csimarket.com/api/v1/companies/CENB/similar
Programmatic access for models, analytics, and integration workflows.

Market Share of the Peer Group, Q3 2021

100%market share
  • Cen Biotech Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Cen Biotech Inc and its 0 tracked competitors.

See Cen Biotech Inc's full market share breakdown »

CENB Stock Performance relative to its Competitors

CENB Competitors (weighted) Percent change over the selected range
Get the full CSIMarket dataset: Subscribe API License